Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI107694

Assay of Total Plasma Apolipoprotein B Concentration in Human Subjects

Gustav Schonfeld, Robert S. Lees, P. K. George, and Barbara Pfleger

1Arteriosclerosis and Clinical Research Centers, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142

Find articles by Schonfeld, G. in: PubMed | Google Scholar

1Arteriosclerosis and Clinical Research Centers, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142

Find articles by Lees, R. in: PubMed | Google Scholar

1Arteriosclerosis and Clinical Research Centers, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142

Find articles by George, P. in: PubMed | Google Scholar

1Arteriosclerosis and Clinical Research Centers, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142

Find articles by Pfleger, B. in: PubMed | Google Scholar

Published May 1, 1974 - More info

Published in Volume 53, Issue 5 on May 1, 1974
J Clin Invest. 1974;53(5):1458–1467. https://doi.org/10.1172/JCI107694.
© 1974 The American Society for Clinical Investigation
Published May 1, 1974 - Version history
View PDF
Abstract

We have developed a double antibody radioimmunoassay (RIA) for human apolipoprotein B (ApoB). The assay measures not only the ApoB content of β-lipoproteins (low density lipoproteins [LDL]) but also that contained in the other lipoproteins in plasma.

Purified lymph and plasma chylomicrons and plasma very low density lipoproteins (VLDL) produced displacement curves in the assay system which paralleled those produced by pure LDL. Thus, the ApoB found in chylomicrons, VLDL, and LDL were immunologically identical. ApoB accounted for about 25 and 35%, respectively, of the total protein of chylomicrons and VLDL by RIA. VLDL and LDL preparations from normal and hyperlipoproteinemic subjects also produced parallel displacement curves, suggesting that the ApoB of normal and hyperlipoproteinemic subjects were immunologically identical. High density lipoproteins and abetalipoproteinemic plasma displaced no counts, nor did the sera of several animal species produce any useful displacement curves in this system.

The fasting total plasma ApoB concentration of normal subjects was 83±16 mg/dl (mean±SD). ApoB levels were high in Type II (162±16), and less so in Type IV (112±24) and Type V (105±17).

When plasma ApoB concentration in Type IV patients was graphed against plasma glycerides, two subpopulations, which may represent different genetic or biochemical subgroups, were apparent.

ApoB concentration in individuals on constant diet and drug regimen was stable over weeks to months. Greater than 90% of ApoB of normal and Type II subjects was in the d > 1.006 plasma fraction. By contrast, only 50-80% of ApoB was in the d > 1.006 fraction in Types IV and V. Thus, hypertriglyceridemia was associated primarily with a redistribution of ApoB to the lighter density fractions; by contrast, in hypercholesterolemia absolute ApoB concentration was markedly increased.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1458
page 1458
icon of scanned page 1459
page 1459
icon of scanned page 1460
page 1460
icon of scanned page 1461
page 1461
icon of scanned page 1462
page 1462
icon of scanned page 1463
page 1463
icon of scanned page 1464
page 1464
icon of scanned page 1465
page 1465
icon of scanned page 1466
page 1466
icon of scanned page 1467
page 1467
Version history
  • Version 1 (May 1, 1974): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts